Macrophage - Mycobacterium tuberculosis interactions: Role of complement receptor 3

Microbial Pathogenesis

Volumn 35, Issue 3, 2003, Pages 125-131

  Velasco Velázquez, Marco Antonio ^a   Barrera, Diana ^a   González Arenas, Aliesha ^a   Rosales, Carlos ^a   Agramonte Hevia, José ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Complement receptor; Integrin; M. tuberculosis; Phagocytosis

Indexed keywords

COMPLEMENT RECEPTOR; DIMER; RECEPTOR SUBUNIT;

ARTICLE; CELL DIVISION; CELL INTERACTION; CELL INVASION; CELL SURVIVAL; INTRACELLULAR SPACE; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; TUBERCULOSIS;

CORYNEBACTERINEAE; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 0043123255     PISSN: 08824010     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0882-4010(03)00099-8     Document Type: Review

References (52)

1. Dye C., Scheele S., Dolin P., Pathania V., Raviglione M.C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA. 282:1999;677-686.
2. Tiruviluamala P., Reichman L.B. Tuberculosis. Annu Rev Public Health. 23:2002;403-426.
3. Schluger N.W. Recent advances in our understanding of human host responses to tuberculosis. Respir Res. 2:2001;157-163.
4. Ernst J.D. Macrophage receptors for Mycobacterium tuberculosis. Infect Immun. 66:1998;1277-1281.
5. Ehlers M.R.W., Daffé M. Interactions between Mycobacterium tuberculosis and host cells: are mycobacterial sugars the key? Trends Microbiol. 6:1998;328-335.
6. Barnes P.F., Chatterjee D., Abrams J.S., et al. Cytokine production induced by Mycobacterium tuberculosis lipoarabinomannan. Relationship to chemical structure. J Immunol. 149:1992;541-547.
7. Toossi Z., Gogate P., Shiratsuchi H., Young T., Ellner J.J. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J Immunol. 154:1995;465-473.
8. Arnaout M.A. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood. 75:1990;1037-1050.
9. Newton R.A., Thiel M., Hogg N. Signaling mechanisms and the activation of leukocyte integrins. J Leukoc Biol. 61:1997;422-426.
10. Bilsland C.A., Diamond M.S., Springer T.A. The leukocyte integrin p150, 95 (CD11b/CD18) as a receptor for iC3b. Activation by a heterologous beta subunit and localization of a ligand recognition site to the I domain. J Immunol. 152:1994;4582-4589.
11. Diamond M.S. Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation. Cell. 65:1991;961-971.
12. Thornton B.P., Vetvicka V., Pitman M., Goldman R.C., Ross G.D. Analysis of the sugar specificity and molecular location of the beta-glucan-binding lectin site of complement receptor type 3 (CD11b/CD18). J Immunol. 156:1996;1235-1246.
13. Hetland G., Wiker H.G. Antigen 85C of Mycobacterium bovis, BCG and M. tuberculosis promotes monocyte-CR3-mediated uptake of microbeads coated with mycobacterial products. Immunology. 82:1994;445-449.
14. Agramonte-Hevia J., Gonzalez-Arenas A., Barrera D., Velasco-Velazquez M.A. Gram-negative bacteria and phagocytic cell interaction mediated by complement receptor 3. FEMS Immunol Med Microbiol. 34:2002;255-266.
15. Oxvig C., Springer T.A. Experimental support for a beta-propeller domain in integrin alpha-subunits and a calcium binding site on its lower surface. Proc Natl Acad Sci USA. 95:1998;4870-4875.
16. Balsam L.B., Liang T.W., Parkos C.A. Functional mapping of CD11b/CD18 epitopes important in neutrophil-epithelial interactions: a central role of the I domain. J Immunol. 160:1998;5058-5065.
17. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell. 110:2002;673-687.
18. Frank M.M., Fries L.F. The role of complement in inflammation and phagocytosis. Immunol Today. 12:1991;322-326.
19. Le Cabec V., Carreno S., Moisand A., Bordier C., Maridonneau-Parini I. Complement receptor 3 (CD11b/CD18) mediates type I and type II phagocytosis during nonopsonic and opsonic phagocytosis, respectively. J Immunol. 169:2002;2003-2009.
20. Schlesinger L.S., Bellinger-Kawahara C.G., Payne N.R., Horwitz M.A. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J Immunol. 144:1990;2771-2780.
21. Dib K., Anderson T. Beta 2 integrin signaling in leukocytes. Front Biosci. 5:2000;438-451.
22. Berton G., Fumagalli L., Laudanna C., Sorio C. Beta 2 integrin-dependent protein tyrosine phosphorylation and activation of the FGR protein tyrosine kinase in human neutrophils. J Cell Biol. 126:1994;1111-1121.
23. 2+ signaling mechanisms of the β2 integrin in neutrophils: involvement of phospholipase C gamma 2 and Ins(1,4,5)P3. Biochem J. 317:1996;403-409.
24. 2+ changes in neutrophils during engagement of CD11b/CD18 integrin visualized using confocal laser scanning reconstruction. J Cell Sci. 109:1996;1689-1694.
25. Hendey B., Klee C.B., Maxfield F.R. Inhibition of neutrophil chemokinesis on vitronectin by inhibitors of calcineurin. Science. 258:1992;296-299.
26. 2+ signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J Exp Med. 191:2000;287-302.
27. Malik Z.A., Iyer S.S., Kusner D.J. Mycobacterium tuberculosis phagosomes exhibit altered calmodulin-dependent signal transduction: contribution to inhibition of phagosome-lysosome fusion and intracellular survival in human macrophages. J Immunol. 166:2001;3392-3401.
28. Guérin I., de Chastellier C. Pathogenic Mycobacteria disrupt the macrophage actin filament network. Infect Immun. 68:2000;2655-2662.
29. Kusner D.J., Hall C.F., Schlesinger L.S. Activation of Phospholipase D is tightly coupled to the phagocytosis of Mycobacterium tuberculosis or opsonized zymosan by human macrophages. J Exp Med. 184:1996;585-595.
30. Iyer S.S., Kusner D.J. Association of Phospholipase D activity with the detergent-insoluble cytoskeleton of U937 promonocytic leukocytes. J Biol Chem. 274:1999;2350-2359.
31. Whitlock B., Gardai S., Fadok V., Bratton D., Henson P.M. Differential roles of alphaM/beta2 integrin clustering or activation in the control of apoptosis via regulation of AKT and ERK survival mechanisms. J Cell Biol. 151:2000;1305-1320.
32. Fratti R.A., Backer J.M., Gruenberg J., Corvera S., Deretic V. Role of phosphatidylinositol 3-kinase and Rab5 effectors in phagosomal biogenesis and mycobacterial phagosome maturation arrest. J Cell Biol. 154:2001;631-644.
33. Peyron P., Maridonneau-Parini I., Stegmann T. Fusion of human neutrophil phagosomes with lysosomes in vitro: involvement of tyrosine kinases of the Src family and inhibition by mycobacteria. J Biol Chem. 276:2001;3512-3517.
34. Cywes C., Godenir N.L., Hoppe H.C., et al. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese Hamster Ovary cells. Infect Immun. 64:1996;5373-5383.
35. Cywes C., Hoppe H.C., Daffé M., Ehlers M.R.W. Nonpsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent. Infect Immun. 65:1997;4258-4266.
36. Ross G.D., Cairn J.A., Lachmann P.J. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin and functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b. J Immunol. 134:1985;3307-3314.
37. Hetland G., Sandven P. Beta-1,3-Glucan reduces growth of Mycobacterium tuberculosis in macrophage cultures. FEMS Immunol Med Microbiol. 33:2002;41-45.
38. Le Cabec V., Cols C., Maridonneau-Parini I. Nonopsonic Phagocytosis of zymosan and Mycobacterium kansasii by CR3 (CD11b/CD18) involves distinct molecular determinants and is or is not coupled with NADPH oxidase activation. Infect Immun. 68:2000;4736-4745.
39. Speert D.P., Silverstein S.C. Phagocytosis of unopsonized zymosan by human monocyte-derived macrophages: maturation and inhibition by mannan. J Leukoc Biol. 38:1985;655-658.
40. Brown G.D., Gordon S. Immune recognition. A new receptor for beta-glucans. Nature. 413:2001;36-37.
41. N'Diaye E.N., Darzacq X., Astarie-Dequeker C., Daffé M., Calafat J., Maridonneau-Parini I. Fusion of azurophil granules with phagosomes and activation of the tyrosine kinase Hck are specifically inhibited during phagocytosis of mycobacteria by human neutrophils. J Immunol. 161:1998;4983-4991.
42. Peyron P., Bordier C., N'Diaye E.N., Maridonneau-Parini I. Nonopsonic phagocytosis of Mycobacterium kansasii by human neutrophils depends on cholesterol and is mediated by CR3 associated with glycosylphosphatidylinositol-anchored proteins. J Immunol. 165:2000;5186-5191.
43. Gatfield J., Pieters J. Essential role for cholesterol in entry of mycobacteria into macrophages. Science. 288:2000;1647-1650.
44. Cougoule C., Constant P., Etienne G., Daffé M., Maridonneau-Parini I. Lack of fusion of azurophil granules with phagosomes during phagocytosis of Mycobacterium smegmatis by human neutrophils is not actively controlled by the bacterium. Infect Immun. 70:2002;1591-1598.
45. Garcia-Garcia E., Rosales C. Signal transduction in Fc receptor-mediated phagocytosis. J Leukoc Biol. 72:2002;1092-1108.
46. Ilangumaran S., Arni S., Poincelet M., et al. Integration of mycobacterial lipoarabinomannans into lycosylphosphatidylinositol-rich domains of lymphomonocytic cell plasma membranes. J Immunol. 155:1995;1334-1342.
47. Thorson L.M., Doxsee D., Scott M.G., Wheeler P., Stokes R.W. Effect of mycobacterial phospholipids on interaction of Mycobacterium tuberculosis with macrophages. Infect Immun. 69:2001;2172-2179.
48. Lien E., Ingalls R.R. Toll-like receptors. Crit Care Med. 30:2002;S1-S11.
49. Stokes R.W., Haidl I.D., Jefferies W.A., Speert D.P. Mycobacteria-macrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages. J Immunol. 151:1993;7067-7076.
50. Melo M.D., Catchpole I.R., Haggar G., Stokes R.W. Utilization of CD11b knockout mice to characterize the role of complement receptor 3 (CR3, CD11b/CD18) in the growth of Mycobacterium tuberculosis in macrophages. Cell Immunol. 205:2000;13-23.
51. Zimmerli S., Edwards S., Ernst J.D. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages. Am J Resp Cell Mol Biol. 15:1996;760-770.
52. Hu C., Mayadas-Norton T., Tanaka K., Chan J., Salgame P. Mycobacterium tuberculosis infection in complement receptor 3-deficient mice. J Immunol. 165:2000;2596-2602.